Use of antithymocyte globulin for treatment of steroid-refractory acute graft-versus-host disease: An international practice survey

Bone Marrow Transplantation

Volumn 28, Issue 10, 2001, Pages 945-950

  Hsu, B ^a   May, R ^a   Carrum, G ^a   Krance, R ^a   Przepiorka, D ^a  

^a CENTER FOR CELL AND GENE THERAPY   (United States)

Author keywords

Antilymphocyte globulin; Antithymocyte globulin; Graft versus host disease; Pediatric; Steroid refractory; Treatment

Indexed keywords

ANTIHISTAMINIC AGENT; CORTICOSTEROID; LYMPHOCYTE ANTIBODY; PARACETAMOL; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CHILD; CLINICAL PRACTICE; CONTROLLED STUDY; DISEASE COURSE; GRAFT VERSUS HOST REACTION; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; PEDIATRIC HOSPITAL; PRIORITY JOURNAL; STATISTICAL ANALYSIS; WESTERN HEMISPHERE;

ACUTE DISEASE; ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; ANIMALS; ANTILYMPHOCYTE SERUM; CHILD; CHILD, PRESCHOOL; DATA COLLECTION; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HORSES; HUMANS; MALE; MIDDLE AGED; PRACTICE GUIDELINES; RABBITS; WORLD HEALTH;

EID: 0035194721     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703269     Document Type: Article

References (21)

1. Treatment of established human graft-vs-host disease by antithymocyte globulin
2. Treatment of graft-versus-host disease in human allogeneic marrow graft recipients: A randomized trial comparing anti thymocyte globulin and corticosteroid
3. Treatment of human acute graft-versus-host disease with antithymocyte globulin and cyclosporine with or without methylprednisolone
4. A retrospective analysis of therapy for acute graft-versus-host disease: Initial treatment
5. A retrospective analysis of therapy for acute graft-versus-host disease: Secondary treatment
6. Acute graft-versus-host disease following unrelated donor marrow transplantation: Failure of conventional therapy
7. ATG plus corticosteroid therapy for acute graft-versus-host disease: Predictors of response and survival
8. Dose-intensified antithymocyte globulin in steroid-resistant graft-versus-host disease after allogeneic marrow or blood stem cell transplantation
9. Treatment of steroid-refractory acute graft-versus-host disease with rabbit antithymocyte globulin
10. A randomized trial comparing prednisone with antithymocyte globulin/prednisone as an initial systemic therapy for moderately severe acute graft-versus-host disease
11. High-dose methylprednisolone therapy for acute graft-versus-host disease associated with matched unrelated donor bone marrow transplantation
12. Therapy of acute graft-versus-host disease (GVHD) - Baltimore experience
13. Early treatment of acute graft-versus-host disease with high- or low-dose 6-methylprednisolone: A multicenter randomized trial from the Italian group for bone marrow transplantation
14. Evaluation of a CD5-specific immunotoxin for treatment of acute graft-versus-host disease after allogeneic marrow transplantation
15. Biological and immunological characterization of ATG and ALG
16. Comparative polyclonal antithymocyte globulin and antilymphocyte/antilymphoblast globulin anti-CD antigen analysis by flow cytometry
17. A prospective study on efficacy and tolerance of antithymocyte globulin Fresenius versus thymoglobuline Merieux after renal transplantation
18. A randomized clinical trial using ATG Fresenius or ATG Merieux as induction therapy in kidney transplantation
19. Results of the double-blind, randomized, multicenter, phase III clinical trial of thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation
20. Improved long-term results with thymoglobuline induction therapy after cardiac transplantation: A comparison of two different rabbit-antithymocyte globulines
21. Sensitization following Thymoglobulin and Atgam rejection therapy as determined with a rapid enzyme-linked immunosorbent assay